4-([1,1'-Biphenyl]-4-yl)-2,6-dichloropyrimidine

Catalog No. :
ACEBRG760
CAS No. :
1385826-81-2
Molecular Formula :
C16H10Cl2N2
Molecular Weight :
301.18

IUPAC Name:4-([1,1'-biphenyl]-4-yl)-2,6-dichloropyrimidine

4-([1,1'-Biphenyl]-4-yl)-2,6-dichloropyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-([1,1'-Biphenyl]-4-yl)-2,6-dichloropyrimidine
IUPAC Name4-([1,1'-biphenyl]-4-yl)-2,6-dichloropyrimidine
MDL No.MFCD29477696
Molecular FormulaC16H10Cl2N2
Molecular Weight301.18
SMILESClC1=CC(C2=CC=C(C3=CC=CC=C3)C=C2)=NC(Cl)=N1
InChI KeyKTLYHIYQPLADGF-UHFFFAOYSA-N
Synonym4-(biphenyl-4-yl)-2,6-dichloropyrimidine;4-(4-Biphenyl)-2,6-dichloropyrimidine;Pyrimidine, 4-[1,1'-biphenyl]-4-yl-2,6-dichloro-;4-[1,1'biphenyl]-4-yl-2,6-dichloropyrimidine;4-(biphenyl-4-yl)-2,5-dichloropyrimidine;4-([1,1'-Biphenyl]-4-yl)-2,6-dichloropyrimidine
CAS No.1385826-81-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEBRG760 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXJG657 route compound structure diagram
    ACKXJG6573764-01-0 In Stock
  2. Plus
  3. ACSVLI572 route compound structure diagram
    ACSVLI5725122-94-1 In Stock
  4. Then
  5. ACEBRG760 route product structure diagram
    ACEBRG7601385826-81-2
Inquiry

2. ACEBRG760 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACEBRG760 route product structure diagram
    ACEBRG7601385826-81-2
Inquiry

Comments (0)